Clay Siegall
Clay Siegall is President and CEO at Immunome. He was President and CEO at Morphimmune and SeaGen. He is a Board Member at Shattuck Labs and was Chairman at Tourmaline Bio.
Morphimmune, led by ex-Seagen CEO Clay Siegall, merges with Immunome in $125M deal to advance oncology therapies
Biotech startup Morphimmune, led by former Seagen CEO Clay Siegall, is merging with public company Immunome in a $125 million deal backed by private investors, creating a new company focused on oncology therapies headquartered in Seattle. Siegall will lead the merged entity as CEO, president, and chairman, building on his track record in drug development and targeting innovative cancer treatment methods.
GeekWire Week in Review (May 14, 2023): Top stories include ex-CFO indicted over $35M crypto transfer, Bezos’ $500M yacht, and Amazon legal/personnel news
GeekWire's Week in Review for May 14, 2023 lists the site's most-read stories, including a Seattle startup ex-CFO indicted over an alleged $35M crypto transfer, Jeff Bezos' $500M yacht, and Amazon-related legal and personnel news.
Seagen Founder Clay Siegall Returns as CEO of Purdue Spinout After Pfizer's $43B Acquisition Deal
Clay Siegall, co-founder and former CEO of Seagen, which is set to be acquired by Pfizer for $43 billion, has returned to biotech as CEO of Purdue University spinout Morphimmune. Despite stepping down amid a personal incident, Siegall remains proud of Seagen’s impact on cancer treatments, particularly in advancing antibody-drug conjugates.
Organizations
See all 5-
Immunome President and CEO 2023–present · current
-
Shattuck Labs Board Member 2024–present · current
-
Tourmaline Bio Chairman 2023–2025 · past
Education
-
The George Washington University Doctor of Philosophy - PhD, Genetics
-
University of Maryland Bachelor of Science - BS, Zoology
Online
Questions about Clay Siegall
Who is Clay Siegall?
Clay Siegall is president and CEO at Immunome, a role Clay began in 2023. Clay was president and CEO at Morphimmune in 2023 and at SeaGen from 1998 to 2022.
What is Clay Siegall known for?
Clay Siegall is known for founding SeaGen and for executive work involving oncology therapies, including leading Morphimmune when it merged with Immunome.
Which organizations is Clay Siegall associated with?
Clay Siegall is associated with 5 organizations, including Immunome as president and CEO from 2023 to present, Morphimmune as president and CEO in 2023, and SeaGen as founder and president and CEO from 1998 to 2022.
Where did Clay Siegall study?
Clay Siegall earned a Doctor of Philosophy - PhD in Genetics at The George Washington University and a Bachelor of Science - BS in Zoology at University of Maryland.
Where is Clay Siegall based?
Clay Siegall is based in the Greater Seattle Area.
Where can I find Clay Siegall online?
Clay Siegall is on LinkedIn.